Stock Earnings

Question 1

SQZ Biotechnologies Co'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, SQZ Biotechnologies Co'in toplam varlıkları $99 olup, net loss $-79'dir.

Question 2

SQZB'ün temel finansal oranları nelerdir?

Accepted Answer

SQZ Biotechnologies Co'in cari oranı 2.35, net kâr marjı -376.19, hisse başına satış $0.72'dir.

Question 3

SQZ Biotechnologies Co'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Currently SQZ Biotechnologies Co data is not available.

Question 4

SQZ Biotechnologies Co kârlı mı?

Accepted Answer

no, son mali tablolara göre SQZ Biotechnologies Co'in net loss $-79'dir.

Question 5

SQZ Biotechnologies Co'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, SQZ Biotechnologies Co'in yükümlülüğü 42'dir.

Question 6

SQZ Biotechnologies Co'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

SQZ Biotechnologies Co'in toplam tedavüldeki hisse sayısı 29.5'dir.

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	12	21	27	21	20	12
Revenue Growth (YoY)	-43%	-22%	28.99%	5%	67%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	20	26	25	20	18	8
Research & Development	51	70	70	51	36	24
Operating Expenses	72	97	95	72	54	33
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-71	-79	-68	-50	-32	-19
Income Tax Expense	--	--	--	--	0	0
Net Income	-71	-79	-68	-50	-32	-20
Net Income Growth	-8%	16%	36%	56%	60%	--
Shares Outstanding (Diluted)	29.49	28.81	27.58	24.79	23.97	23.97
Shares Change (YoY)	1%	4%	11%	3%	0%	--
EPS (Diluted)	-2.43	-2.76	-2.49	-2.04	-1.34	-0.84
EPS Growth	-8%	11%	22%	52%	60%	--
Free Cash Flow	-74	-84	-82	-44	-35	19
Free Cash Flow Per Share	-2.5	-2.91	-2.97	-1.77	-1.46	0.79
Gross Margin	--	--	--	--	--	--
Operating Margin	-500%	-357.14%	-251.85%	-242.85%	-170%	-166.66%
Profit Margin	-591.66%	-376.19%	-251.85%	-238.09%	-160%	-166.66%
Free Cash Flow Margin	-616.66%	-400%	-303.7%	-209.52%	-175%	158.33%
EBITDA	-59	-74	-67	-50	-33	-19
EBITDA Margin	-491.66%	-352.38%	-248.14%	-238.09%	-165%	-158.33%
D&A For EBITDA	1	1	1	1	1	1
EBIT	-60	-75	-68	-51	-34	-20
EBIT Margin	-500%	-357.14%	-251.85%	-242.85%	-170%	-166.66%
Effective Tax Rate	--	--	--	--	0%	0%

SQZ Biotechnologies Co (SQZB) Price